What should you know about early prostate cancer treatment?

A diagnosis does not automatically point to one treatment. Doctors review the biopsy findings, prostate-specific antigen pattern, examination, imaging, tumour grade, and whether disease appears confined to the prostate. They also consider age, other health conditions, urinary and sexual function, and how a person weighs treatment effects against active monitoring.

When treatment is recommended, prostate removal surgery removes the prostate and is sometimes performed with robotic assistance. Radiotherapy directs radiation at the prostate, while brachytherapy places radioactive sources in or near the prostate. These approaches can affect urine flow, bowel habits, erections, and fertility in different ways, so the likely effects and recovery plan deserve a clear discussion.

Ask the urology or oncology team to explain the biopsy and imaging results in plain language. Keep copies of reports and write down urinary symptoms, medicines, and existing conditions. Difficulty passing urine can have several causes, including non-cancerous prostate enlargement, but new or worsening difficulty should be assessed rather than assumed to be part of the cancer.

Compare the purpose, timing, practical demands, and possible effects of each option. Some people may be offered active surveillance with planned reviews when the cancer appears low risk; others may need treatment intended to remove or control the tumour. Targeted radioisotope therapy and bone-strengthening therapy are generally discussed in different disease settings, such as cancer that has spread, rather than assumed for every early diagnosis.

Seek urgent help if you cannot pass urine, have severe lower abdominal pain, or develop new weakness or numbness in the legs. Contact the treatment team promptly for fever, heavy bleeding, inability to keep fluids down, or rapidly worsening pain after a procedure. These signs need medical assessment and may relate to treatment or another urinary problem.

Ask how the cancer grade and stage affect the choices, whether active surveillance is reasonable, and what monitoring would involve. Ask how surgery, radiotherapy, or brachytherapy could affect urine, bowel function, erections, and fertility; how side effects are managed; and whether a second opinion could clarify the decision.